CMIC CMO USA Corporation is a member of the CMIC Group, a company with facilities in 8 countries and over 5900 employees worldwide. Our FDA-registered facility is located in Central New Jersey. We specialize in the formulation development and GMP commercial manufacturing of NDA and ANDA solid dosage products with expertise in sustained and controlled release products. We will guide you towards regulatory approval and commercial launch while also helping you reduce your development cycles and capital costs.
Paul Skultety, Alex McClung, Ted Koontz and Damian Gant, Xcelience, a division of Capsugel Dosage Form Solutions||May 5, 2016 What does a one-stop shop really mean and is it always best for the client?
Tim Wright, Editor||March 9, 2016 Contract Pharma asked a roundtable of business leaders from Symbiosis, Grifols, Althea, LSNE and Baxter to discuss key trends in the parenteral dosage development and manufacturing market
James E. Gregory, UPM Pharmaceuticals||October 7, 2015 Pharmaceutical and biopharmaceutical companies large and small are increasingly relying on third-party providers for support at all stages of drug development. To realize efficiencies, they are at the same time reducing the number of suppliers to a preferred few with whom they can form strategic partnerships.
Julie Kuriakose , UPM Pharmaceuticals ||May 1, 2014 Comparing manufacturing methods for one immediate-release low-dose form, we found that dry blend needed less equipment and was more “QbD-ready” than wet granulation or geometric dilution.